Top Message
KIDS WELL, ALL WELL
For the Future
New Biologics Business
Biosimilars Business
New biotech business (cell therapy)
Pipeline
Our Philosophy
Access
Organization
History
News
Financial Highlights
IR Library
IR Calendar
IR FAQs
IR Policy / Disclaimer
2020/11/09
2020/09/18
2020/08/20
2020/07/15
2020/05/25
2020/04/08
2020/03/23
2020/03/16
2020/03/05
2020/02/19
2020/02/17
2020/02/14
2020/02/05
Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2020
2020/01/30
2020/01/22
2020/01/21
2020/01/06